USPTO Trademark Registration: Gold 'N Hot Curling Iron

The USPTO has registered the trademark 'Gold 'N Hot' for an electric variable temperature curling iron. The trademark application was originally filed in 1982 and officially registered on March 25, 2026.

USPTO Trademark Registration: MOLECULAR

The USPTO has registered the trademark 'MOLECULAR' for an electrical steamer used for setting hair and removing wrinkles from fabrics. The trademark was registered on March 25, 2026, with a filing date of March 30, 1983.

USPTO Trademark Registration for PHASE3

The United States Patent and Trademark Office (USPTO) has registered the trademark PHASE3 for computer programs recorded on tapes or disks. The application was originally filed in 1983 and officially registered on March 25, 2026.

USPTO EONVIEW Trademark Application Published

The United States Patent and Trademark Office (USPTO) has published the EONVIEW trademark application for opposition. The application covers a range of computing and electronic products, including display screens, computer hardware, and consumer electronics.

NETVAULT Trademark Registration

The United States Patent and Trademark Office (USPTO) has registered the trademark NETVAULT for software used in data archiving, backup, and restoration for enterprises. The registration was finalized on March 25, 2026, based on a filing date of February 1, 2001.

Cash Or Crap Trademark Application

The USPTO has received an intent-to-use trademark application for 'Cash Or Crap' filed on March 24, 2026. The application covers downloadable electronic game programs. This is a routine filing for a new trademark.

VIRENALORA Trademark Publication for Opposition

The USPTO has published the trademark application for VIRENALORA for opposition. The application covers various electronic goods including USB cables, headphones, smart watches, and computer accessories. The publication date is March 25, 2026.

Silkdusk Trademark Application Published for Opposition

The USPTO has published the trademark application for 'Silkdusk' for opposition. The application covers a range of computing and electronics products, including electric locks, smartwatches, and computer peripherals. The publication date is March 25, 2026.

USPTO Trademark Publication: Kinetic Truth Engine

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'Kinetic Truth Engine' for opposition. The application covers downloadable software for AI-based sports performance verification and related SaaS services.

USPTO Trademark Registration - Spicer Power Transmission Mechanisms

The United States Patent and Trademark Office (USPTO) has registered trademark TM72045536 for Spicer, covering power transmission mechanisms such as gears, gear boxes, and torque converters. The registration date is March 25, 2026, with a filing date of February 10, 1958.

Kollsman Trademark Registration for Aircraft Instruments

The USPTO has registered trademark TM72113115 for Kollsman, covering a range of aircraft instruments. The trademark was registered on March 25, 2026, with a filing date of February 6, 1961.

IOPC: BTP Officer Receives Final Written Warning for Excessive Force on Children

The UK's Independent Office for Police Conduct (IOPC) has issued a final written warning to a British Transport Police officer for using excessive force against two children during an arrest. The officer struck both children with his baton shortly after encountering them at London Bridge station.

USPTO Patent Application for Peptoid Nucleic Acid Delivery

The USPTO has published a patent application (US20260083769A1) detailing novel hydroxyalkyl-capped cationic peptoids for nucleic acid delivery. The application, filed by inventors from various institutions, describes compositions and methods for delivering polyanionic compounds to cells and eliciting immune responses.

USPTO Patent Application: CD70 Antibody Drug Conjugates

The USPTO has published a new patent application (US20260083853A1) detailing CD70 antibody drug conjugates for treating cancer and autoimmune diseases. The application was filed on October 25, 2023, by inventors Xiao Shang and others.

USPTO Patent Application: Antibody Conjugates with Bis-MSPT Linker

The USPTO has published a new patent application (US20260083854A1) detailing antibody conjugates that utilize a bis-MSPT linker. The application, filed by inventors Riazul Alam, Guillermo S. Cortez, and Yan Wang, describes pharmaceutical compositions and methods related to these conjugates.

USPTO Patent Application for Immunoconjugates

The USPTO has published a new patent application, US20260083855A1, filed by Hoffmann-La Roche Inc. The application relates to immunoconjugates comprising a mutant interleukin-2 polypeptide and an antibody that binds to PD-1. This filing is part of the standard patent application process.

USPTO Patent Application for Capsid Polypeptides

The USPTO has published a new patent application (US20260083863A1) from Dyno Therapeutics, Inc. for capsid polypeptides designed for payload delivery. The application details specific polypeptide sequences and their methods of use in therapeutic applications.

USPTO Patent Application: Sustained Transgene Expression of Modified ERT2 Peptide Fusion

The USPTO has published a patent application (US20260083859A1) detailing a novel fusion polypeptide for sustained transgene expression. The application, filed by inventors from various institutions, describes targeting constructs for inducible cell death systems using modified estrogen receptor ligand binding domains.

USPTO Patent Application: Compositions Targeting Endothelial Cells

The USPTO has published a patent application from Harvard College detailing novel compositions for targeting endothelial cells. These compositions, which include binders, linkers, and radioactive isotopes, are intended for selective delivery to cells and treating diseases, including cancer.

USPTO Patent Application: Recombinant Human Type III Collagen for Angiogenesis

The USPTO has published a patent application (US20260083883A1) detailing recombinant human type III collagen designed to promote angiogenesis. The application describes modifications to natural type III collagen to enhance its angiogenic function and adhesion properties, potentially increasing the angiogenesis rate by over 37%.

USPTO Patent Application: Anti-DPP3 Antibody Formulations

The USPTO has published a patent application from 4TEEN4 Pharmaceuticals GmbH for formulations and dosage amounts for administering an anti-DPP3 antibody or fragment thereof to humans. The application, filed on August 26, 2025, details potential treatments for life-threatening circulatory failure conditions such as shock.

USPTO Patent Application: Thiazolidine Linkers for Protein-Drug Conjugates

The USPTO has published a new patent application (US20260083856A1) detailing thiazolidine linkers for protein-drug conjugates and their uses in treating diseases. The application was filed on September 11, 2025, and is scheduled for publication on March 26, 2026.

USPTO Patent Application: Cancer Treatment with Anti-CD20 Antibody and Acylfulvenes

The USPTO has published a patent application (US20260083691A1) filed by Lantern Pharma Inc. The application describes a method for treating cancer by combining an anti-CD20 antibody with acylfulvenes. This patent application is related to novel therapeutic combinations for B-cell cancers.

USPTO Patent Application: CARs for Hidradenitis Suppurativa Treatment

The USPTO has published a patent application (US20260083777A1) filed by Sonoma Biotherapeutics, Inc. The application describes chimeric antigen receptors (CARs) designed to target citrullinated polypeptides for the treatment of hidradenitis suppurativa.

USPTO Patent Application for Generating CD4 T Cells

The USPTO has published a patent application (US20260083778A1) for methods of generating CD4 T cells from progenitor cells. The application, assigned to Boston Medical Center Corporation, describes a specific differentiation process for therapeutic use.

USPTO Patent Application: Engineered Probiotics Expressing Anti-Inflammatory Molecules

The USPTO has published a patent application (US20260083783A1) from the University of Cincinnati for engineered probiotics that express anti-inflammatory molecules. The application details a genetically modified E. coli bacterium designed to produce a microbial anti-inflammatory molecule (MAM) protein.

USPTO Patent Application for CsgA-Derived Nanostructures for Antigen Delivery

The USPTO has published a patent application (US20260083834A1) for CsgA-derived nanostructures designed for antigen delivery. The application details self-assembling polypeptides conjugated to immunogens that form nanofilaments to stimulate immune responses, potentially for vaccines against various conditions.

USPTO Patent Application: Phage T4 Nanoparticle Vaccine Platform

The USPTO has published a patent application (US20260083835A1) detailing a modular bacteriophage T4 nanoparticle vaccine platform. This platform is designed for the rapid development of dual COVID-19 and flu mucosal vaccines, administered intranasally without an adjuvant.

USPTO Patent Application: Modified Coronavirus Spike Antigen Protein

The USPTO has published a patent application (US20260083836A1) for a modified coronavirus spike antigen protein. The application describes a protein designed to suppress cell membrane fusion ability and improve safety by modifying cleavage sites, aiming to enhance vaccine efficacy and antibody production.

USPTO Patent Application: Treating NSCLC with Dostarlimab or Biosimilar

The USPTO has published a patent application detailing a method for treating non-small cell lung cancer (NSCLC) using dostarlimab or a biosimilar. The application outlines a treatment approach for patients previously treated with an immune checkpoint inhibitor.

USPTO Patent Application: NEO-201 Antibody for Suppressing Myeloid Derived Suppressor Cells

The USPTO has published a patent application (US20260083840A1) detailing methods for ablating myeloid derived suppressor cells using the NEO-201 antibody. The application describes the antibody's specific binding to certain O-glycans and its potential use in treating cancers and infectious diseases by suppressing gMDSCs.

Bispecific Molecule Stabilizing Composition Patent Application

The USPTO has published a patent application (US20260083841A1) for a pharmaceutical composition designed to stabilize bispecific antigen-binding molecules at increased concentrations. The composition includes buffer agents, saccharides, and specific stabilizing agents like EDTA or citric acid.

USPTO Patent Application: IL-17 Antibody Compositions

The USPTO has published a patent application (US20260083842A1) detailing pharmaceutical products and stable liquid compositions of IL-17 antibodies, such as secukinumab. The application covers methods of making these compositions and their use in treating IL-17-mediated disorders, including autoimmune conditions like psoriasis and rheumatoid arthritis.

USPTO Patent Application for Anti-PD-1 Antibody-IL-2 Immunoconjugate Formulations

The USPTO has published a new patent application (US20260083857A1) for anti-PD-1 antibody-IL-2 immunoconjugate formulations. The application details stable pharmaceutical formulations comprising anti-human PD-1 antibody-modified human interleukin-2 immunoconjugates.

USPTO Patent Application: Antibody Drug Conjugate Comprising NMT Inhibitor

The USPTO has published a new patent application (US20260083858A1) related to antibody drug conjugates (ADCs) that comprise an NMT inhibitor conjugated to an antibody via a linker. The application details the inventors and abstract of the invention.

Emergency Sirens Test Scheduled for April 7

The Delaware Division of Public Health announced a scheduled test of emergency sirens for Tuesday, April 7, 2026, at 7:20 PM. This test is part of the state's emergency preparedness measures, particularly concerning the Salem/Hope Creek Nuclear Generating Station.

MDE Approves Air Permit for Frederick Data Center

The Maryland Department of the Environment (MDE) has approved an air quality permit for Amazon Data Services, Inc. for emergency backup generators at a new data center campus in Frederick. The permit ensures generators will only be used during emergencies and includes continuous oversight under the Clean Air Act.

ICO fines TMAC Ltd £100,000 for PECR breaches

The UK's Information Commissioner's Office (ICO) has fined TMAC Ltd £100,000 for breaches of the Privacy and Electronic Communications Regulations (PECR). The company made over 260,000 unsolicited marketing calls to individuals registered on the Telephone Preference Service and failed to provide required caller information.

EPA Authorizes Florida Hazardous Waste Program Revisions

The EPA has granted final authorization for revisions to Florida's hazardous waste management program under RCRA. This action is effective May 26, 2026, unless adverse comments are received by April 27, 2026. The revisions were submitted by Florida on September 1, 2023.

Florida Hazardous Waste Program Revisions Authorized by EPA

The EPA is proposing to authorize revisions to Florida's hazardous waste management program. This action would allow Florida to implement and enforce these revised program elements under the Resource Conservation and Recovery Act (RCRA). The public comment period for this proposed rule closes on April 27, 2026.

EPA Seeks Comment on Clean Water Act Financial Capability Guidance

The Environmental Protection Agency (EPA) is seeking public comment on draft guidance for assessing financial capability under the Clean Water Act (CWA). This guidance aims to help states and tribes evaluate the financial capacity of entities to comply with water quality standards and permits.

EPA Modifies Privacy Act System of Records

The EPA is proposing to modify a Privacy Act system of records to add a new routine use as required by Executive Order 14249 and OMB Memorandum M-25-32. The agency is also updating contact information for the Agency Privacy Officer. The comment period for this notice closes on April 27, 2026.

EPA TSCA Confidential Business Information Renewal for OMB Review

The Environmental Protection Agency (EPA) has submitted a renewal request for its collection of TSCA Confidential Business Information (CBI) to the Office of Management and Budget (OMB) for review and approval. This notice provides an opportunity for public comment on the information collection activities.

EPA Approves Iowa Air Quality Regulations Revisions

The Environmental Protection Agency (EPA) has published a proposed rule to approve revisions to Iowa's air quality regulations. This action is part of the EPA's review process for state implementation plans under the Clean Air Act. The public has a comment period to provide input on the proposed approval.

EPA Proposes Hazardous Waste Delisting for WRB Refining

The Environmental Protection Agency (EPA) has proposed to delist hazardous waste generated by WRB Refining from the hazardous waste regulations under the Resource Conservation and Recovery Act (RCRA). This proposed rule is open for public comment.

Energy Conservation Program: Representative Average Unit Costs of Energy

The Department of Energy has published a notice regarding the representative average unit costs of energy for consumer products. These updated costs will become effective on April 27, 2026, and will remain in effect until further notice.

National Cooperative Research Act: MLCommons Association Membership Changes

The DOJ Antitrust Division has published a notice regarding changes to the membership of MLCommons Association under the National Cooperative Research and Production Act of 1993. Several new members have been added, and two members have withdrawn from the association.

DOJ Notice on Biopharmaceutical Manufacturing Preparedness Consortium Membership Changes

The DOJ Antitrust Division published a notice regarding changes to the membership of the Biopharmaceutical Manufacturing Preparedness Consortium (BIOMAP-CONSORTIUM). The consortium filed notifications disclosing new parties added to the group research project, which is intended to extend the National Cooperative Research and Production Act's provisions limiting antitrust plaintiff recovery to actual damages.

ODVA, Inc. Membership Changes Under National Cooperative Research Act

The Antitrust Division published a notice regarding ODVA, Inc. under the National Cooperative Research and Production Act. ODVA reported changes in its membership, adding two foreign parties and removing four foreign parties from its research venture. This notice serves to maintain the limitations on antitrust damages for the venture.

1EdTech Consortium Membership Changes Under National Cooperative Research Act

The Antitrust Division has published a notice regarding changes in membership for the 1EdTech Consortium, Inc., filed under the National Cooperative Research and Production Act of 1993. Several new members have joined, and others have withdrawn from the consortium.